Study: Tirzepatide improves blood sugar control in children with poorly controlled type 2 diabetes
Post Details (Top)
Desktop Banner (This ad will be displayed on screens larger than 992px)
Mobile Banner (This ad will be displayed on screens smaller than 992px)
New research shows that the diabetes/obesity medication tirzepatide can cause clinically meaningful improvements in blood sugar control and weight loss in children and adolescents with type 2 diabetes aged 10–17 years whose diabetes and weight are inadequately controlled with an existing treatment regimen of metformin, insulin, or both.
In-Article-1
Desktop Banner (This ad will be displayed on screens larger than 992px)
Mobile Banner (This ad will be displayed on screens smaller than 992px)
In-Article-2 Desktop Banner (This ad will be displayed on screens larger than 992p
Mobile Banner (This ad will be displayed on screens smaller than 992px)
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
Carver
Carver who carves the news
Post Details (Bottom)
Desktop Banner (This ad will be displayed on screens larger than 992px)
Mobile Banner (This ad will be displayed on screens smaller than 992px)
